Clinical Trial Update: A Study of WVT078 in Patients With Multiple Myeloma (MM) [Phase 1]

View source ↗

Summary

A Phase 1 study of WVT078 in patients with multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• WVT078

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Myeloma (MM) | Phase 1 | Status: TERMINATED